Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brinzolamide Brimonidine Atr

Deadline: 10 May 2026

Germany

Ref. No.: 8307469

EMD:Ref Document

Bid Value: Ref Document

370 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pomalidomide

Deadline: 10 May 2026

Germany

Ref. No.: 8305884

EMD:Ref Document

Bid Value: Ref Document

370 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bosutinib

Deadline: 10 May 2026

Germany

Ref. No.: 8305728

EMD:Ref Document

Bid Value: Ref Document

370 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Brinzolamide Brimonidine Official Atc Code S01Ec24

Deadline: 31 Oct 2025

Germany

Ref. No.: 8302226

EMD:Ref Document

Bid Value: Ref Document

179 Days Left

Sdp Supply Of Medicinal Products

Deadline: 31 Aug 2027

Bulgaria

Ref. No.: 8296308

EMD:Ref Document

Bid Value: Ref Document

848 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Omalizumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 8294730

EMD:Ref Document

Bid Value: Ref Document

462 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Prednisolone Atr

Deadline: 10 May 2026

Germany

Ref. No.: 8280171

EMD:Ref Document

Bid Value: Ref Document

370 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Iron Ii Ion Ret

Deadline: 10 May 2026

Germany

Ref. No.: 8279497

EMD:Ref Document

Bid Value: Ref Document

370 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ciprofloxacin Oht Atr

Deadline: 10 May 2026

Germany

Ref. No.: 8271966

EMD:Ref Document

Bid Value: Ref Document

370 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Betamethasone Salicylic Acid Loe

Deadline: 10 May 2026

Germany

Ref. No.: 8267865

EMD:Ref Document

Bid Value: Ref Document

370 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brinzolamide Brimonidine Atr

Deadline: 10 May 2026

Germany

Ref. No.: 8267412

EMD:Ref Document

Bid Value: Ref Document

370 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg

Deadline: 10 May 2026

Germany

Ref. No.: 8260726

EMD:Ref Document

Bid Value: Ref Document

370 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1 N2

Deadline: 10 May 2026

Germany

Ref. No.: 8259327

EMD:Ref Document

Bid Value: Ref Document

370 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Somatropin Genotropin

Deadline: 10 Aug 2026

Germany

Ref. No.: 8099325

EMD:Ref Document

Bid Value: Ref Document

462 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Trastuzumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 8091920

EMD:Ref Document

Bid Value: Ref Document

462 Days Left

Showing 48016 to 48030 of 48323 results

‹
1
2
...
3199
3200
3201
3202
3203
3204
3205
...
3221
3222
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!